We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
12 hedge funds and large institutions have $19.2M invested in ESSA Pharma in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more funds holding
Funds holding: 10 → 12 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
27% less capital invested
Capital invested by funds: $26.4M → $19.2M (-$7.2M)
Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$178K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$78.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.43K |
Top Sellers
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$66.8K |
| 2 |
Morgan Stanley
New York
|
-$46.1K |